These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27456348)

  • 1. Metastatic thyroid carcinoma presenting as malignant pleural effusion: A cytologic review of 5 cases.
    Vyas M; Harigopal M
    Diagn Cytopathol; 2016 Dec; 44(12):1085-1089. PubMed ID: 27456348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologic Features and Immunocytochemical Profiles of Malignant Effusions with Metastatic Papillary Thyroid Carcinoma: A Case Series from a Single Institution.
    Lew M; Pang JC; Roh MH; Jing X
    Acta Cytol; 2015; 59(5):412-7. PubMed ID: 26587773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic breast carcinoma in pleural fluid: Correlation of receptor and HER2 status with the primary carcinoma-a pilot study.
    Francis IM; Alath P; George SS; Jaragh M; Al Jassar A; Kapila K
    Diagn Cytopathol; 2016 Dec; 44(12):980-986. PubMed ID: 27666130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant pleural effusion from papillary thyroid carcinoma diagnosed by pleural effusion cytology: A case report.
    Kosmas K; Tsonou A; Mitropoulou G; Salemi E; Kazi D; Theofanopoulou A
    Diagn Cytopathol; 2018 Feb; 46(2):204-207. PubMed ID: 28960907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
    Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
    Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic thyroid carcinoma mimicking a malignant pleural mesothelioma: Clues for diagnosis.
    Capron T; Giusiano S; Bourinet V; Laroumagne S; Dutau H; Astoul P
    Thorac Cancer; 2019 Nov; 10(11):2175-2178. PubMed ID: 31529678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant pleural effusion resulting from metastasis of thyroid primaries: a cytomorphological analysis.
    Olson MT; Nuransoy A; Ali SZ
    Acta Cytol; 2013; 57(2):177-83. PubMed ID: 23406984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study.
    El Hag MI; Ha J; Farag R; El Hag AM; Michael CW
    Diagn Cytopathol; 2016 Sep; 44(9):731-6. PubMed ID: 27338760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic transformation of papillary thyroid carcinoma in multiple lung metastases presenting with a malignant pleural effusion: a case report.
    Abe T; Suzuki M; Shimizu K; Shinagawa N; Oizumi S; Matsuno Y; Miyazaki M; Tanino M; Tanaka S; Nishimura M
    J Med Case Rep; 2014 Dec; 8():460. PubMed ID: 25532447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of metastatic papillary thyroid carcinoma in FNA specimens using thyroid peroxidase immunohistochemistry.
    Shield PW; Crouch SJ; Papadimos DJ; Walsh MD
    Cytopathology; 2018 Jun; 29(3):227-232. PubMed ID: 29508480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX2 and PAX8: useful markers for metastatic effusions.
    Waters L; Crumley S; Truong L; Mody D; Coffey D
    Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
    Lew M; Pang JC; Jing X; Fields KL; Roh MH
    Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions.
    Wiseman W; Michael CW; Roh MH
    Diagn Cytopathol; 2011 Sep; 39(9):651-6. PubMed ID: 20949455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
    Chernock RD; El-Mofty SK; Becker N; Lewis JS
    Am J Surg Pathol; 2013 Aug; 37(8):1215-22. PubMed ID: 23681073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin: A comparative study with their pulmonary counterparts.
    Bi Y; Deng Y; Li S; Zhou X; Chen Y; Ma D; Mao X; Guan Y; Chen J; Meng Y
    J Surg Oncol; 2016 Nov; 114(6):697-702. PubMed ID: 27761900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of thyroglobulin washout studies in predicting cervical lymph node metastases: One academic medical center's experience.
    Tang S; Buck A; Jones C; Sara Jiang X
    Diagn Cytopathol; 2016 Dec; 44(12):964-968. PubMed ID: 27546053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant effusions secondary to metastatic thyroid carcinomas: A review of 15 cases.
    Mustafa MA; Malenie R; Mir F; Hamadeh F; Policarpio-Nicolas ML
    Cancer Cytopathol; 2023 Feb; 131(2):136-143. PubMed ID: 36219535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant pleural effusions due to small-cell lung carcinoma: a cytologic and immunocytochemical study.
    Chhieng DC; Ko EC; Yee HT; Shultz JJ; Dorvault CC; Eltoum IA
    Diagn Cytopathol; 2001 Dec; 25(6):356-60. PubMed ID: 11747231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid transcription factor-1 immunocytochemical staining of pleural fluid cytocentrifuge preparations for detection of small cell lung carcinoma.
    Liu J; Farhood A
    Acta Cytol; 2004; 48(5):635-40. PubMed ID: 15471255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.